Direct oral anticoagulant secondary prophylaxis vs Low molecular weight heparin secondary prophylaxis
Minor non‐GI bleeding · patients with cancer with venous thromboembolism
Direct oral anticoagulant secondary prophylaxis probably leads to higher minor non‐GI bleeding compared with low molecular weight heparin secondary prophylaxis (moderate certainty).
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyRR 2.37 [1.44, 3.89]2 studies · 1495 participantsModerate